Clinical Trials Directory

Trials / Unknown

UnknownNCT02862158

Frequency Doubling Technology (FDT) Mobile Visual Field Testing

Evaluation of Different Frequency Doubling Technology (FDT) Mobile Devices for Visual Field Assessment

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
500 (estimated)
Sponsor
University of Miami · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This is a single center, prospective study to evaluate the efficacy and reproducibility of frequency doubling technology (FDT)-based visual field devices compared to conventional Humphrey Visual Field (HVF) perimetry. The investigators plan to enroll 500 patients in this study.

Detailed description

Glaucoma is a leading cause of irreversible and preventable blindness world-wide. Insufficient evidence exists to support routine screening for glaucoma in a primary care setting due to the relatively low prevalence of the disease (Guirguis-Blake, 2005 and Moyer, 2013). Frequency doubling technology (FDT)-based perimetry is a relatively inexpensive and portable visual field testing device with a short testing time that has shown reasonable efficacy, sensitivity and specificity in screening for glaucoma in clinic- and community-based settings (Mansberger, 2005 and Nomoto 2009). The aim of our study is to compare the efficacy and reproducibility of FDT perimetry platforms compared with Humphrey Visual Field (HVF) perimetry (which is the gold clinical standard in clinics and hospitals) in detecting glaucomatous visual field defects.

Conditions

Interventions

TypeNameDescription
DEVICEFDT visual field
DEVICEStandard HVF

Timeline

Start date
2016-08-01
Primary completion
2022-11-01
Completion
2022-11-01
First posted
2016-08-10
Last updated
2020-10-30

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02862158. Inclusion in this directory is not an endorsement.